Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Xeris Pharmaceuticals Inc
XERS | US
6.05
USD0.10
1.68%
XERS | US
Loading StockChartView...
About Xeris Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
6.05
Open
5.98
High
6.07
Low
5.89
Xeris Biopharma Holdings Inc. a biopharmaceutical company engages in developing and commercializing therapies in Illinois. The company markets Gvoke a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis a therapy for the treatment of hyperkalemic hypokalemic and related variants of primary periodic paralysis; and Recorlev a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago Illinois.
View LessXERS | US
Risk
44.7
Sharpe
0.70
Luna's Score
51/100
Recommendation
Hold
Luna says (XERS | US)
What's Working
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
46.3%1 month
44.7%3 months
45.4%6 months
57.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.34
Debt to equity
-13.99
Debt to assets
0.81
Ent. to EBITDA
-3.36
Ent. to rev.
3.57
PEG
-
Other Fundamentals
EBITDA
-25.00M
MarketCap
901.44M
MarketCap(USD)
901.44M
Div. yield
-
Op. margin
-17.03
Erngs. growth
-
Rev. growth
26.50
Ret. on equity
-617.16
Short ratio
6.26
Short perc.
7.63
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.64
Range1M
1.16
Range3M
2.40
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.65
Price X volume
6.06M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.36 | 0.53 | Cheaper |
| Ent. to Revenue | 3.57 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.34 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 45.45 | 72.80 | Lower Risk |
| Debt to Equity | -13.99 | -1.23 | Cheaper |
| Debt to Assets | 0.81 | 0.25 | Expensive |
| Market Cap | 901.44M | 3.66B | Emerging |
